Mumps and ovarian cancer: modern interpretation of an historic association
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Epidemiologic studies found childhood mumps might protect against ovarian cancer. To explain this association, we investigated whether mumps might engender immunity to ovarian cancer through antibodies against the cancer-associated antigen MUC1 abnormally expressed in the inflamed parotid gland.
Through various health agencies, we obtained sera from 161 cases with mumps parotitis. Sera were obtained from 194 healthy controls. We used an ELISA to measure anti-MUC1 antibodies and electro-chemiluminescence assays to measure MUC1 and CA 125. Log-transformed measurements were analyzed by t-tests, generalized linear models, and Pearson or Spearman correlations. We also conducted a meta-analysis of all published studies regarding mumps and ovarian cancer.
Adjusting for assay batch, age, and sex, the level of anti-MUC1 antibodies was significantly higher in mumps cases compared to controls (p = 0.002). Free circulating levels of CA 125, but not MUC1, were also higher in cases (p = 0.02). From the meta-analysis, the pooled odds ratio estimate (and 95% CI) for the mumps and ovarian cancer association was 0.81 (0.68–0.96) (p = 0.01).
Mumps parotitis may lead to expression and immune recognition of a tumor-associated form of MUC1 and create effective immune surveillance of ovarian cancer cells that express this form of MUC1.
- Mumps and ovarian cancer: modern interpretation of an historic association
Cancer Causes & Control
Volume 21, Issue 8 , pp 1193-1201
- Cover Date
- Print ISSN
- Online ISSN
- Springer Netherlands
- Additional Links
- Ovarian cancer
- Mumps parotitis
- Industry Sectors
- Author Affiliations
- 1. Department of Obstetrics and Gynecology Epidemiology Center, Obstetrics and Gynecology Epidemiology Center, Brigham and Women’s Hospital (BWH), Harvard Medical School, 221 Longwood Ave, RFB 366, Boston, MA, 02115, USA
- 2. US Food and Drug Administration, Silver Spring, MD, USA
- 3. Department of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
- 4. Laboratory of Genital Tract Biology, Department of Obstetrics, Gynecology and Reproductive Biology, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA
- 5. Centre for Infections, Health Protection Agency, London, UK
- 6. Division of Microbiology, Department of Pathology and Laboratory Medicine, Queen Elizabeth II Health Sciences Centre, Halifax, NS, Canada
- 7. Department of Pathology, Dalhousie University, Halifax, NS, Canada